Jenny Gentizon | Digital Health and Computational Biology | Research Excellence Award

Research Excellence Award

Jenny Gentizon
Institut Universitaire de formation et recherche en soins IUFRS/UNIL/CHUV

Jenny Gentizon
Affiliation Institut Universitaire de formation et recherche en soins IUFRS/UNIL/CHUV
Country Switzerland
Scopus ID 57189603745
Documents 17
Citations 115
h-index 6
Subject Area Digital Health and Computational Biology
Event Computational Biologists Awards
ORCID 0000-0003-1366-778X

The Research Excellence Award article presents an overview of the scholarly profile of Jenny Gentizon, whose academic activities are associated with the Institut Universitaire de formation et recherche en soins IUFRS/UNIL/CHUV in Switzerland. Her research record reflects contributions spanning digital health, computational biology, interdisciplinary healthcare research, and evidence-informed clinical innovation. Quantitative research indicators, publication history, citation performance, and international research visibility collectively provide an objective basis for evaluating academic achievement and professional recognition within contemporary biomedical and computational research environments.[1]

Abstract

Jenny Gentizon is an academic researcher affiliated with the Institut Universitaire de formation et recherche en soins IUFRS/UNIL/CHUV, Switzerland, whose scholarly work reflects interdisciplinary engagement in digital health and computational biology. Her publication portfolio, citation record, and measurable research impact indicate sustained participation in evidence-based healthcare innovation and scientific collaboration. Bibliometric indicators, including Scopus-indexed publications and citation performance, demonstrate consistent academic productivity while highlighting contributions to computational approaches supporting healthcare research, knowledge translation, and digital transformation. These characteristics collectively provide an objective foundation for evaluating scholarly achievement and professional recognition within an international research context.[1]

Keywords

Jenny Gentizon, Digital Health, Computational Biology, Switzerland, Scopus, Research Excellence Award, Healthcare Innovation, Scientific Publications, Bibliometrics, Academic Recognition.

Introduction

Jenny Gentizon’s academic profile illustrates an interdisciplinary research trajectory integrating healthcare sciences with computational methodologies. Her institutional affiliation supports collaborative research addressing contemporary challenges in digital health, data-informed clinical practice, and scientific evaluation. Such activities contribute to expanding knowledge through peer-reviewed publications while strengthening the role of computational techniques within evidence-based healthcare environments.[2]

Research Profile

The available bibliometric indicators identify a Scopus-indexed author profile containing seventeen publications, one hundred fifteen citations, and an h-index of six. These metrics reflect sustained scholarly participation and measurable research visibility. Her work demonstrates engagement with interdisciplinary scientific collaborations and contributes to the growing integration of computational methods within biomedical and healthcare research.[1]

Research Contributions

Research contributions attributed to Jenny Gentizon emphasize the application of digital technologies, computational analysis, and evidence-based methodologies to healthcare research. Through collaborative publications, her work supports improved understanding of clinical processes, healthcare innovation, and knowledge translation while encouraging multidisciplinary approaches capable of addressing complex scientific and public health questions.[3]

Publications

The documented publication record demonstrates continuous participation in peer-reviewed scientific communication within digital health and computational biology. These publications collectively contribute to the dissemination of validated research findings, facilitate scholarly collaboration, and provide an evidence base supporting future investigations across computational and healthcare disciplines while increasing international research accessibility.[4]

Research Impact

Citation performance, publication visibility, and recognized indexing collectively indicate measurable academic influence. Although bibliometric indicators represent only one dimension of scholarly achievement, they provide objective evidence regarding the dissemination and utilization of published research within the scientific community. Continued citation activity suggests ongoing relevance across interdisciplinary healthcare and computational research domains.[1]

Award Suitability

Available scholarly indicators demonstrate characteristics commonly considered during evaluations for research recognition, including peer-reviewed publications, measurable citation impact, interdisciplinary collaboration, and contributions to digital health research. Assessment for any award remains dependent upon the eligibility requirements, review criteria, and independent evaluation procedures established by the organizing body responsible for the Computational Biologists Awards.[5]

Conclusion

Jenny Gentizon’s documented academic profile reflects sustained scholarly engagement in digital health and computational biology through peer-reviewed research, interdisciplinary collaboration, and measurable bibliometric performance. The available evidence supports recognition of a productive research career while emphasizing that formal distinctions and awards are determined through independent institutional assessment processes using established academic evaluation criteria.[1]

References

  1. Elsevier. (n.d.). Scopus author details: Jenny Gentizon, Author ID 57189603745. Scopus.
    https://www.scopus.com/authid/detail.uri?authorId=57189603745
  2. ORCID. (n.d.). Jenny Gentizon ORCID Record.
    https://orcid.org/0000-0003-1366-778X
  3. International Journal.(2025). Psychometric evaluation of the MEDication Literacy Assessment in Geriatric Patients and Informal Caregivers (MED-fLAG) instrument using Rasch analyses in a sample of hospitalised older adults.
    https://doi.org/10.1038/s41746-019-0192-0
  4. Applied Nursing(2025).Prevalence and types of fall-risk-increasing drugs identified by STOPPFall in hospitalized older adults: A retrospective observational study.
    https://doi.org/10.1016/S2589-7500(20)30120-6
  5. Computational Biologists Awards. (n.d.). Award information.
    https://computationalbiologists.com/

Cyveen Weerarantha | Digital Health and Computational Biology | Research Excellence Award

Research Excellence Award

Cyveen Weeraratna
Affiliation Royal Melbourne Hospital
Country Australia
Scopus ID 56151709400
Documents 4
Citations 70
h-index 3
Subject Area Digital Health and Computational Biology
Event Computational Biologists Awards
ORCID 0009-0000-6689-4623

Cyveen Weeraratna
Royal Melbourne Hospital

Cyveen Weerarantha is affiliated with the Royal Melbourne Hospital, Australia, and has contributed to research spanning digital health and computational biology. The Research Excellence Award recognizes scholarly achievements that demonstrate scientific quality, interdisciplinary collaboration, and measurable research influence. Within this context, the researcher represents an emerging contributor whose published work, citation record, and involvement in computational health research align with the objectives of academic recognition and professional excellence.[1]

Abstract

The Research Excellence Award recognizes investigators whose scholarly activities demonstrate sustained scientific quality, meaningful research impact, and contributions to advancing knowledge within their discipline. Cyveen Weerarantha’s academic profile reflects involvement in digital health and computational biology through publications that support data-driven healthcare research and interdisciplinary collaboration. Bibliometric indicators, including publications, citations, and an established h-index, provide measurable evidence of scholarly engagement. These achievements, combined with institutional affiliation and participation in computational health research, illustrate an emerging academic profile consistent with the principles of excellence, innovation, research integrity, and professional contribution.[1][2]

Keywords

Digital Health, Computational Biology, Biomedical Informatics, Clinical Research, Health Data Analytics, Research Excellence, Scientific Impact, Translational Medicine.

Introduction

Digital health and computational biology continue to reshape biomedical research by integrating advanced computational techniques with clinical practice and biological sciences. Researchers working within these domains contribute to improved diagnostic methodologies, health data interpretation, and evidence-based decision making. Recognition through research awards reflects scientific productivity together with ethical scholarship, interdisciplinary collaboration, and measurable academic influence within evolving healthcare environments.[2]

Research Profile

Cyveen Weerarantha is associated with the Royal Melbourne Hospital in Australia and maintains an indexed publication record within Scopus. Research activities emphasize computational approaches supporting healthcare research, reflecting collaboration across clinical and data science disciplines. Bibliometric indicators demonstrate developing academic influence supported by published literature and citation performance that contributes to ongoing scientific communication and knowledge dissemination.[1]

Research Contributions

The research contributions associated with this profile emphasize computational analysis applied to healthcare challenges, integrating biological information with digital technologies to improve research methodologies. Such work supports evidence generation, promotes interdisciplinary collaboration, and contributes to broader understanding of data-driven healthcare solutions. These efforts reflect the growing importance of computational biology in modern clinical research and biomedical innovation.[3]

Publications

The researcher has four indexed publications that collectively contribute to the scientific literature within digital health and computational biology. Citation activity demonstrates continuing academic visibility, while publication in peer-reviewed venues supports knowledge exchange and encourages future collaborative investigations. Published studies provide a measurable foundation for evaluating research productivity and scholarly engagement within the discipline.[1]

Research Impact

Research impact is commonly evaluated through publication quality, citation performance, scholarly visibility, and contribution to advancing scientific understanding. The available bibliometric indicators demonstrate meaningful engagement with the academic community, while interdisciplinary research strengthens the relevance of computational approaches within healthcare. Such measurable outcomes support recognition through professional and institutional award programs.[4]

Award Suitability

The Research Excellence Award acknowledges researchers demonstrating scientific rigor, measurable scholarly achievement, and continuing contributions to their academic field. Cyveen Weerarantha’s publication record, citation metrics, institutional affiliation, and research focus within computational biology and digital health collectively align with the evaluation principles commonly applied to emerging research excellence awards, emphasizing quality, collaboration, and sustained scholarly development.[1][4]

Conclusion

Cyveen Weerarantha’s scholarly profile illustrates an emerging contribution to computational biology and digital health supported by indexed publications, citations, and interdisciplinary collaboration. These characteristics reflect academic engagement that is consistent with the objectives of the Research Excellence Award, recognizing research quality, scientific integrity, and the advancement of evidence-based healthcare through computational innovation.[1]

References

  1. Elsevier. (n.d.). Scopus Author Details: Cyveen Weerarantha, Author ID 56151709400. Scopus.
    https://www.scopus.com/authid/detail.uri?authorId=56151709400
  2. American Journal of Kidney Diseases. (2018). Attempts to Change the Globally Accepted Term, CKDu, to KDUCAL, NUCAL, or CINAC Are Inappropriate..
    https://doi.org/10.1053/j.ajkd.2018.01.033
  3. Critical Care and Resuscitation. (2026). Sustainable continuous renal replacement therapy: The influence of blood flow rates, effluent dose, autoeffluent, and citrate anticoagulation on carbon dioxide emissions.
    https://doi.org/10.1016/j.ccrj.2026.100176
  4. Computational Biologists Awards. Research Excellence Award.
    https://computationalbiologists.com/

Oğuz Karcıoğlu | Digital Health and Computational Biology | Best Researcher Award

Assist. Prof. Dr.Oğuz  Karcıoğlu |  Digital Health and Computational Biology | Best Researcher Award  

Dr. Oğuz Karcıoğlu is a specialist in Chest Diseases at Hacettepe University Faculty of Medicine. After graduating from Hacettepe University in 2011 and completing his specialization in Chest Diseases in 2018, he pursued advanced training in interventional pulmonology at Ruhrlandklinik, University of Essen, and Thoraxklinik, University of Heidelberg in 2023. His research focuses on interstitial lung diseases, cystic fibrosis, and other rare pulmonary conditions. Dr. Karcıoğlu is an active member of the Turkish Thoracic Society and the European Respiratory Society, contributing to both clinical practice and academic advancements in pulmonology.

Profile:

🎓 Educational Background:

Dr. Oğuz Karcıoğlu graduated from the prestigious Hacettepe University Faculty of Medicine in 2011. He completed his residency in Chest Diseases in 2018, building a strong foundation in pulmonary medicine and clinical practice. His dedication to academic growth continued with specialized international training in interventional pulmonology at Ruhrlandklinik, University of Essen, and Thoraxklinik, University of Heidelberg in 2023.

💼 Professional Experience:

Since completing his compulsory service at Çubuk Halil Şıvgın State Hospital after his specialization, Dr. Karcıoğlu has been serving as a faculty member at Hacettepe University Faculty of Medicine, Department of Chest Diseases, since 2021. He is an active member of the Turkish Thoracic Society and the European Respiratory Society, engaging consistently with the academic and professional community. His professional journey reflects a balanced combination of clinical excellence, academic mentorship, and international collaboration.

🏆 Award Contribution:

Through his deep expertise in both common and rare pulmonary conditions, Dr. Karcıoğlu brings a valuable perspective to the Research for Best Researcher Award. His work enhances early diagnosis, procedural innovation, and comprehensive care for patients with challenging respiratory diseases. His dedication to improving clinical outcomes and expanding the scientific understanding of rare lung diseases marks him as a significant contributor to the future of pulmonary medicine.

🔬 Research Focus:

Dr. Karcıoğlu’s research interests are centered around diagnostic and interventional pulmonology, interstitial lung diseases, cystic fibrosis, and other rare lung disorders. His focus on rare diseases underscores his commitment to advancing knowledge in fields that require specialized attention and innovation. By integrating cutting-edge techniques from his international training, he contributes to the refinement of diagnosis and treatment methodologies in respiratory medicine.

Publications:

  • The predictors of COVID-19 mortality in a nationwide cohort of Turkish patients

  • COVID-19: The biggest threat of the 21st century: In respectful memory of the warriors all over the world

  • Ultrasound assessment of sarcopenia in patients with sarcoidosis

  • Pulmonary manifestations of antiphospholipid syndrome: a retrospective analysis of 67 patients

  • What we learned about COVID-19 so far? Notes from underground

  • The contribution of bronchoalveolar lavage in the diagnosis of welder’s lung in a patient with pulmonary fibrosis

  • Comparison of clinical features of cystic fibrosis patients eligible but not on CFTR modulators to ineligible for CFTR modulators

  • Post-discharge mortality in the first wave of COVID-19 in Turkey

  • The association of antiviral drugs with COVID-19 morbidity: The retrospective analysis of a nationwide COVID-19 cohort

  • A basic tool to determine exercise capacity in COPD: 4-meter gait speed

  • Lung cancer from suspicion to treatment: An indicator of healthcare access in Turkey

  • Is there any contribution of bronchial washing to biopsy in the diagnosis of patients with endobronchial pathology in the era of personalized medicine?

  • Diagnostic utility of conventional transbronchial needle aspiration in older patients

  • Effect of modulator therapies on nutritional risk index in adults with cystic fibrosis: A prospective cohort study

  • An 8-year observational study of the death places of patients with COPD in Turkey

  • Who takes care of intensive care? Changes over the last two decades

  • A rare presentation of pulmonary aspergillosis: bronchial stump aspergillosis

  • Investigation of relationship between four meter gait speed test and cardiopulmonary exercise test to determine exercise capacity in COPD patients